Case Study

Advanced Bioscience Laboratories Inc. (ABL) Scaled Up Lentiviral Production

Source: Cytiva
Pall image 3 450 300

The use of lentivirus vector in the production of CAR-T and gene therapies is increasing. Frequently, lentiviral vector production is conducted in multi-layered flatware vessels or fixed-bed bioreactors like the popular iCELLis bioreactor. The iCELLis bioreactor system is a fixed-bed bioreactor comprised of carriers made of non-woven medical-grade polyethylene terephthalate (PET) fibers. The iCELLis bioreactor provides optimal growing conditions for adherent cells employing a closed, automated, single-use platform.

A recent experiment was conducted by Advanced BioScience Laboratories and Pall to scale up a lentivirus process from the iCELLis Nano bioreactor to the iCELLis 500+ bioreactor with very little development work. The goal was to produce lentiviral titers in the iCELLis 500+ bioreactor greater than or equal to the iCELLis Nano bioreactor and to use nutrient and metabolite analysis to determine if cell growth is similar between the two.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online